{"entity":{"type":"insider","cik":"0001843817","url":"/insider/0001843817","json_url":"/insider/0001843817.json","name":"Verstandig Grant","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":4,"first":"2021-02-19","last":"2022-06-07","span_basis":"filed_date"},"name_variants":[{"name":"Verstandig Grant","source":"filing","n_filings":4,"first_seen":"2021-02-19","last_seen":"2022-06-07"}],"transactions":[{"id":6672049,"accession":"0001209191-22-034895","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-034895","line_url":"/filing/0001209191-22-034895#line-3","is_derivative":false,"issuer_cik":"0001538210","issuer_name":"NexImmune, Inc.","issuer_ticker":"NEXI","issuer_name_source":null,"issuer_url":"/issuer/0001538210","owner_cik":"0001843817","owner_name":"Verstandig Grant","owner_display_name":"Verstandig Grant","owner_url":"/insider/0001843817","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26876.0,"shares_display":"26,876","price_per_share":2.284,"price_display":"2.28","price_state":"stated","total_value":61384.784,"total_display":"61,384.78","total_whole":"61,385","shares_owned_after":1105495.0,"shares_owned_after_display":"1,105,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-07","filed_date":"2022-06-07","scope":"insider"},{"id":6672045,"accession":"0001209191-22-034895","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-034895","line_url":"/filing/0001209191-22-034895#line-2","is_derivative":false,"issuer_cik":"0001538210","issuer_name":"NexImmune, Inc.","issuer_ticker":"NEXI","issuer_name_source":null,"issuer_url":"/issuer/0001538210","owner_cik":"0001843817","owner_name":"Verstandig Grant","owner_display_name":"Verstandig Grant","owner_url":"/insider/0001843817","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.1415,"price_display":"2.14","price_state":"stated","total_value":53537.5,"total_display":"53,537.50","total_whole":"53,538","shares_owned_after":1078619.0,"shares_owned_after_display":"1,078,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-07","scope":"insider"},{"id":6672043,"accession":"0001209191-22-034895","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-034895","line_url":"/filing/0001209191-22-034895#line-1","is_derivative":false,"issuer_cik":"0001538210","issuer_name":"NexImmune, Inc.","issuer_ticker":"NEXI","issuer_name_source":null,"issuer_url":"/issuer/0001538210","owner_cik":"0001843817","owner_name":"Verstandig Grant","owner_display_name":"Verstandig Grant","owner_url":"/insider/0001843817","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.2249,"price_display":"2.22","price_state":"stated","total_value":33373.5,"total_display":"33,373.50","total_whole":"33,374","shares_owned_after":1053619.0,"shares_owned_after_display":"1,053,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-07","scope":"insider"},{"id":6496781,"accession":"0001209191-22-033728","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-033728","line_url":"/filing/0001209191-22-033728#line-3","is_derivative":false,"issuer_cik":"0001538210","issuer_name":"NexImmune, Inc.","issuer_ticker":"NEXI","issuer_name_source":null,"issuer_url":"/issuer/0001538210","owner_cik":"0001843817","owner_name":"Verstandig Grant","owner_display_name":"Verstandig Grant","owner_url":"/insider/0001843817","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":47900.0,"shares_display":"47,900","price_per_share":2.2272,"price_display":"2.23","price_state":"stated","total_value":106682.88,"total_display":"106,682.88","total_whole":"106,683","shares_owned_after":1038619.0,"shares_owned_after_display":"1,038,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-02","scope":"insider"},{"id":6496779,"accession":"0001209191-22-033728","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-033728","line_url":"/filing/0001209191-22-033728#line-2","is_derivative":false,"issuer_cik":"0001538210","issuer_name":"NexImmune, Inc.","issuer_ticker":"NEXI","issuer_name_source":null,"issuer_url":"/issuer/0001538210","owner_cik":"0001843817","owner_name":"Verstandig Grant","owner_display_name":"Verstandig Grant","owner_url":"/insider/0001843817","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40200.0,"shares_display":"40,200","price_per_share":2.3821,"price_display":"2.38","price_state":"stated","total_value":95760.42,"total_display":"95,760.42","total_whole":"95,760","shares_owned_after":990719.0,"shares_owned_after_display":"990,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-02","scope":"insider"},{"id":6496777,"accession":"0001209191-22-033728","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-033728","line_url":"/filing/0001209191-22-033728#line-1","is_derivative":false,"issuer_cik":"0001538210","issuer_name":"NexImmune, Inc.","issuer_ticker":"NEXI","issuer_name_source":null,"issuer_url":"/issuer/0001538210","owner_cik":"0001843817","owner_name":"Verstandig Grant","owner_display_name":"Verstandig Grant","owner_url":"/insider/0001843817","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45024.0,"shares_display":"45,024","price_per_share":2.1126,"price_display":"2.11","price_state":"stated","total_value":95117.7024,"total_display":"95,117.70","total_whole":"95,118","shares_owned_after":950519.0,"shares_owned_after_display":"950,519","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-31","filed_date":"2022-06-02","scope":"insider"},{"id":6694185,"accession":"0001209191-22-021311","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-021311","line_url":"/filing/0001209191-22-021311#line-3","is_derivative":false,"issuer_cik":"0001538210","issuer_name":"NexImmune, Inc.","issuer_ticker":"NEXI","issuer_name_source":null,"issuer_url":"/issuer/0001538210","owner_cik":"0001843817","owner_name":"Verstandig Grant","owner_display_name":"Verstandig Grant","owner_url":"/insider/0001843817","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18983.0,"shares_display":"18,983","price_per_share":3.76,"price_display":"3.76","price_state":"stated","total_value":71376.08,"total_display":"71,376.08","total_whole":"71,376","shares_owned_after":905495.0,"shares_owned_after_display":"905,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-28","filed_date":"2022-03-28","scope":"insider"},{"id":6694182,"accession":"0001209191-22-021311","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-021311","line_url":"/filing/0001209191-22-021311#line-2","is_derivative":false,"issuer_cik":"0001538210","issuer_name":"NexImmune, Inc.","issuer_ticker":"NEXI","issuer_name_source":null,"issuer_url":"/issuer/0001538210","owner_cik":"0001843817","owner_name":"Verstandig Grant","owner_display_name":"Verstandig Grant","owner_url":"/insider/0001843817","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":131622.0,"shares_display":"131,622","price_per_share":4.14,"price_display":"4.14","price_state":"stated","total_value":544915.08,"total_display":"544,915.08","total_whole":"544,915","shares_owned_after":886512.0,"shares_owned_after_display":"886,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-25","filed_date":"2022-03-28","scope":"insider"},{"id":6694179,"accession":"0001209191-22-021311","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-021311","line_url":"/filing/0001209191-22-021311#line-1","is_derivative":false,"issuer_cik":"0001538210","issuer_name":"NexImmune, Inc.","issuer_ticker":"NEXI","issuer_name_source":null,"issuer_url":"/issuer/0001538210","owner_cik":"0001843817","owner_name":"Verstandig Grant","owner_display_name":"Verstandig Grant","owner_url":"/insider/0001843817","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":39995.0,"shares_display":"39,995","price_per_share":3.35,"price_display":"3.35","price_state":"stated","total_value":133983.25,"total_display":"133,983.25","total_whole":"133,983","shares_owned_after":754890.0,"shares_owned_after_display":"754,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-24","filed_date":"2022-03-28","scope":"insider"},{"id":4223237,"accession":"0001209191-21-012361","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-012361","line_url":"/filing/0001209191-21-012361#line-2","is_derivative":false,"issuer_cik":"0001538210","issuer_name":"NexImmune, Inc.","issuer_ticker":"NEXI","issuer_name_source":null,"issuer_url":"/issuer/0001538210","owner_cik":"0001843817","owner_name":"Verstandig Grant","owner_display_name":"Verstandig Grant","owner_url":"/insider/0001843817","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":175000.0,"shares_display":"175,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":2975000.0,"total_display":"2,975,000.00","total_whole":"2,975,000","shares_owned_after":714895.0,"shares_owned_after_display":"714,895","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001538210","name":"NexImmune, Inc.","url":"/issuer/0001538210","role":"Director","n_filings":4,"first_seen":"2021-02-19","last_seen":"2022-06-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001843817","retrieved_at":"2026-08-27T10:38:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}